The 2.5 mg starter dose will remain priced at $349 for the first month of treatment. In clinical trials, patients on the 15 mg dose lost an average of 48 pounds, the release said. The new vial ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk. The full data from the 751-subject SURMOUNT-5 ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...

WASHINGTON, D.C.—Are some ultra-processed foods good for you? Could diet change be better than Wegovy or Ozempic for weight loss? What role does nutrition play in breast and prostate cancers, ...

Entering text into the input field will update the search result below Home page Seeking Alpha - Power to Investors Create free account ...